BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19747374)

  • 1. Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex.
    Mozaffari M; Hoogeveen-Westerveld M; Kwiatkowski D; Sampson J; Ekong R; Povey S; den Dunnen JT; van den Ouweland A; Halley D; Nellist M
    BMC Med Genet; 2009 Sep; 10():88. PubMed ID: 19747374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.
    Nellist M; Sancak O; Goedbloed M; Adriaans A; Wessels M; Maat-Kievit A; Baars M; Dommering C; van den Ouweland A; Halley D
    BMC Med Genet; 2008 Feb; 9():10. PubMed ID: 18302728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex.
    Hoogeveen-Westerveld M; Ekong R; Povey S; Karbassi I; Batish SD; den Dunnen JT; van Eeghen A; Thiele E; Mayer K; Dies K; Wen L; Thompson C; Sparagana SP; Davies P; Aalfs C; van den Ouweland A; Halley D; Nellist M
    Hum Mutat; 2012 Mar; 33(3):476-9. PubMed ID: 22161988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reliable cell-based assay for testing unclassified TSC2 gene variants.
    Coevoets R; Arican S; Hoogeveen-Westerveld M; Simons E; van den Ouweland A; Halley D; Nellist M
    Eur J Hum Genet; 2009 Mar; 17(3):301-10. PubMed ID: 18854862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
    Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
    Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
    Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex.
    Jin F; Jiang K; Ji S; Wang L; Ni Z; Huang F; Li C; Chen R; Zhang H; Hu Z; Zha X
    Hum Mol Genet; 2017 Jan; 26(2):407-419. PubMed ID: 28013293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large deletion at the TSC1 locus in a family with tuberous sclerosis complex.
    Nellist M; Sancak O; Goedbloed MA; van Veghel-Plandsoen M; Maat-Kievit A; Lindhout D; Eussen BH; de Klein A; Halley DJ; van den Ouweland AM
    Genet Test; 2005; 9(3):226-30. PubMed ID: 16225402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
    Inoki K; Li Y; Zhu T; Wu J; Guan KL
    Nat Cell Biol; 2002 Sep; 4(9):648-57. PubMed ID: 12172553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
    Santiago Lima AJ; Hoogeveen-Westerveld M; Nakashima A; Maat-Kievit A; van den Ouweland A; Halley D; Kikkawa U; Nellist M
    PLoS One; 2014; 9(4):e93940. PubMed ID: 24714658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB; Aronica E; Baltuch G; Nathanson KL
    Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.
    Jones AC; Shyamsundar MM; Thomas MW; Maynard J; Idziaszczyk S; Tomkins S; Sampson JR; Cheadle JP
    Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.
    Kwiatkowski DJ
    Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction.
    Hoogeveen-Westerveld M; Exalto C; Maat-Kievit A; van den Ouweland A; Halley D; Nellist M
    Biochim Biophys Acta; 2010 Sep; 1802(9):774-81. PubMed ID: 20547222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
    Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.